gadolinium dtpa has been researched along with Optic Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekiesińska-Figatowska, M; Jurkiewicz, E; Kmieć, T; Mierzewska, H; Pakua-Kościesza, I; Pronicka, E; Scheper, G; van der Knaap, MS | 1 |
| Carmody, RF; Goodwin, JA; Haery, C; Mafee, MF; Small, K | 1 |
2 other study(ies) available for gadolinium dtpa and Optic Atrophy
| Article | Year |
|---|---|
MRI of a family with leukoencephalypathy with vanishing white matter.
Topics: Adolescent; Amino Acid Substitution; Aspartic Acid; Brain; Case-Control Studies; Cerebellar Ataxia; Child; Choline; Contrast Media; Creatine; Female; Gadolinium DTPA; Heredodegenerative Disorders, Nervous System; Humans; Lactic Acid; Magnetic Resonance Imaging; Muscle Spasticity; Optic Atrophy; Point Mutation; Siblings | 2005 |
Orbital and optic pathway sarcoidosis: MR findings.
Topics: Adolescent; Adult; Cavernous Sinus; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Lacrimal Apparatus Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Ophthalmoplegia; Optic Atrophy; Optic Chiasm; Optic Nerve Diseases; Orbital Diseases; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Sarcoidosis | 1994 |